126 related articles for article (PubMed ID: 38150941)
21. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.
Sorenmo KU; Baez JL; Clifford CA; Mauldin E; Overley B; Skorupski K; Bachman R; Samluk M; Shofer F
J Vet Intern Med; 2004; 18(2):209-13. PubMed ID: 15058772
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.
Heishima K; Mori T; Sakai H; Sugito N; Murakami M; Yamada N; Akao Y; Maruo K
PLoS One; 2015; 10(9):e0137361. PubMed ID: 26335793
[TBL] [Abstract][Full Text] [Related]
23. Comparative aspects and clinical outcomes of canine renal hemangiosarcoma.
Locke JE; Barber LG
J Vet Intern Med; 2006; 20(4):962-7. PubMed ID: 16955823
[TBL] [Abstract][Full Text] [Related]
24. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
[TBL] [Abstract][Full Text] [Related]
25. The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression.
Gulay KCM; Aoshima K; Kim S; Kitaguchi R; Kobayashi A; Kimura T
Vet Comp Oncol; 2022 Jun; 20(2):529-534. PubMed ID: 34927338
[TBL] [Abstract][Full Text] [Related]
26. Biological and molecular characterization of a canine hemangiosarcoma-derived cell line.
Thamm DH; Dickerson EB; Akhtar N; Lewis R; Auerbach R; Helfand SC; MacEwen EG
Res Vet Sci; 2006 Aug; 81(1):76-86. PubMed ID: 16256156
[TBL] [Abstract][Full Text] [Related]
27. Primary Hemangiosarcoma of the Falciform Fat in Seven Dogs (2007-2015).
Mendez SE; Sykes Crumplar SE; Durham AC
J Am Anim Hosp Assoc; 2020; 56(2):120-126. PubMed ID: 31961215
[No Abstract] [Full Text] [Related]
28. Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.
Kodama A; Sakai H; Matsuura S; Murakami M; Murai A; Mori T; Maruo K; Kimura T; Masegi T; Yanai T
BMC Cancer; 2009 Oct; 9():363. PubMed ID: 19825192
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.
Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA
Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-214 and MicroRNA-126 Are Potential Biomarkers for Malignant Endothelial Proliferative Diseases.
Heishima K; Mori T; Ichikawa Y; Sakai H; Kuranaga Y; Nakagawa T; Tanaka Y; Okamura Y; Masuzawa M; Sugito N; Murakami M; Yamada N; Akao Y; Maruo K
Int J Mol Sci; 2015 Oct; 16(10):25377-91. PubMed ID: 26512652
[TBL] [Abstract][Full Text] [Related]
31. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
[TBL] [Abstract][Full Text] [Related]
32. Use of routine histopathology and factor VIII-related antigen/von Willebrand factor immunohistochemistry to differentiate primary hemangiosarcoma of bone from telangiectatic osteosarcoma in 54 dogs.
Giuffrida MA; Bacon NJ; Kamstock DA
Vet Comp Oncol; 2017 Dec; 15(4):1232-1239. PubMed ID: 27507032
[TBL] [Abstract][Full Text] [Related]
33. Role of monocyte recruitment in hemangiosarcoma metastasis in dogs.
Regan DP; Escaffi A; Coy J; Kurihara J; Dow SW
Vet Comp Oncol; 2017 Dec; 15(4):1309-1322. PubMed ID: 27779362
[TBL] [Abstract][Full Text] [Related]
34. High drug efflux pump capacity and low DNA damage response induce doxorubicin resistance in canine hemangiosarcoma cell lines.
Morita A; Aoshima K; Gulay KCM; Onishi S; Shibata Y; Yasui H; Kobayashi A; Kimura T
Res Vet Sci; 2019 Dec; 127():1-10. PubMed ID: 31648115
[TBL] [Abstract][Full Text] [Related]
35. Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma.
Rodriguez AM; Graef AJ; LeVine DN; Cohen IR; Modiano JF; Kim JH
J Vet Intern Med; 2015; 29(4):1088-97. PubMed ID: 26118793
[TBL] [Abstract][Full Text] [Related]
36. Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.
Sorenmo K; Samluk M; Clifford C; Baez J; Barrett JS; Poppenga R; Overley B; Skorupski K; Oberthaler K; Van Winkle T; Seiler G; Shofer F
J Vet Intern Med; 2007; 21(6):1347-54. PubMed ID: 18196746
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
Adachi M; Hoshino Y; Izumi Y; Takagi S
J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
[TBL] [Abstract][Full Text] [Related]
38. VAC protocol for treatment of dogs with stage III hemangiosarcoma.
Alvarez FJ; Hosoya K; Lara-Garcia A; Kisseberth W; Couto G
J Am Anim Hosp Assoc; 2013; 49(6):370-7. PubMed ID: 24051260
[TBL] [Abstract][Full Text] [Related]
39. Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium.
Fosmire SP; Dickerson EB; Scott AM; Bianco SR; Pettengill MJ; Meylemans H; Padilla M; Frazer-Abel AA; Akhtar N; Getzy DM; Wojcieszyn J; Breen M; Helfand SC; Modiano JF
Lab Invest; 2004 May; 84(5):562-72. PubMed ID: 15064773
[TBL] [Abstract][Full Text] [Related]
40. Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives.
Kim JH; Graef AJ; Dickerson EB; Modiano JF
Vet Sci; 2015 Nov; 2(4):388-405. PubMed ID: 29061949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
